Introduction: Tardive Dyskinesia (TD) is a serious movement disorder that can arise as a side effect of antipsychotic medications, affecting patients’ quality of life. In rare cases, TD can lead to complications such as jaw subluxation, causing pain and functional impairment. This article explores a recent case study on TD-induced jaw subluxation and its clinical implications. Visit https://www.clinmedcasereportsjournal.org/acr for more groundbreaking research in this field.
Main Content Sections:
Case Summary: A Rare but Serious Complication
A recent study reported a case of an 80-year-old woman with TD who developed jaw subluxation after prolonged use of multiple antipsychotic medications, including haloperidol, brexpiprazole, risperidone, and olanzapine. The patient, initially treated for psychosis and paranoia, experienced severe motor symptoms, including tremors and dysarthria, before developing jaw dislocation.
Clinical Implications and Management
- TD is often irreversible and worsens over time if not properly managed.
- Risk Factors: Long-term antipsychotic use, particularly in elderly patients, increases the likelihood of developing TD and associated complications.
- Treatment Approaches:
- Discontinuation or modification of antipsychotic therapy.
- Introduction of alternative medications such as VMAT2 inhibitors (tetrabenazine, deutetrabenazine, valbenazine) to help manage TD symptoms.
- Emergency intervention for jaw subluxation, including manual reduction procedures and pain management strategies.
Integration of External Medical Sources: The American Psychiatric Association (APA) emphasizes that prevention remains the best strategy against TD. Physicians should regularly evaluate patients on long-term antipsychotic therapy to minimize the risk of severe motor side effects.
Further Reading and Resources: For a detailed analysis, read the full study at https://doi.org/10.29328/journal.acr.1001112. Additionally, explore related topics in our journal archives for more insights into movement disorders and their management.
Call-to-Action (CTA) for Engagement: Explore more studies at https://www.clinmedcasereportsjournal.org/acr and share your thoughts in the comments below!
Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reuse of this material will not be handled by the author of this article.
You may provide us with feedback in the comments section.


Leave a comment